Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Hydroxycamptothecin Market by Type (99% (HPLC), 98% (HPLC), Other), By Application (Pharmaceutical Intermediats, Lab Reagent, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Hydroxycamptothecin Market by Type (99% (HPLC), 98% (HPLC), Other), By Application (Pharmaceutical Intermediats, Lab Reagent, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 326726 4200 Pharma & Healthcare 377 123 Pages 4.9 (36)
                                          

Market Overview:


The global hydroxycamptothecin market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for hydroxycamptothecin in pharmaceutical intermediates, lab reagents, and other applications. Hydroxycamptothecin is a type of camptothecin that is used as an anticancer agent. It inhibits topoisomerase I, which leads to DNA damage and apoptosis in cancer cells. The high efficacy of hydroxycamptothecin against various types of cancer makes it an attractive anticancer agent for use in the treatment of various cancers.


Global Hydroxycamptothecin Industry Outlook


Product Definition:


Hydroxycamptothecin (HCPT) is a topoisomerase I inhibitor isolated from the Camptotheca acuminata tree. It is an anticancer drug used to treat ovarian cancer, small cell lung cancer, and colorectal cancer.


99% (HPLC):


99% (HPLC) is a form of hydroxycamptothecin developed by Genscript. It is an analog of camptothecin and has been shown to have greater activity in vitro against some human cancer cell lines. The drug was approved in South Korea for the treatment of advanced renal cell carcinoma in April 2016, and it received approval for its use worldwide following the publication of its phase II clinical trial results in 2017.


98% (HPLC):


98% (HPLC) is a method used for the separation of camptothecin and its derivatives. It is also used as an internal standard to measure the concentration of camptothecin in samples. 98% (HPLC) can separate both neutral and acidic forms of camptothecin, but it cannot separate other alkaloids such as N-desmethylcamptocin or N-oxide which are found in very small quantities.


Application Insights:


The other application segment includes cosmetics and personal care products. The product is anticipated to gain traction in the cosmetic industry owing to its anti-aging properties. It has been observed that hydroxycamptothecin acts as a ¢â‚¬Å“biological clock¢â‚¬ for cells, which may lead to skin aging effects such as wrinkles and loss of skin firmness. Thus, it is being considered for use in anti-wrinkle creams and moisturizers by the cosmetic industry.


Hydroxycamptothecin also finds applications in pharmaceutical intermediates due to its ability to act as an antioxidant, which helps prevent damage caused by free radicals present during chemical synthesis procedures used during drug development (R&D). This allows manufacturers of drugs/pharmaceuticals with longer shelf life before they are released for consumption; this factor is expected drive demand over the forecast period.


Regional Analysis:


North America was the largest regional market in 2017 owing to high product demand from pharmaceutical intermediates and lab reagents application. The region is expected to maintain its dominance over the forecast period due to increasing hydroxycamptothecin-based drug development activities. Asia Pacific is projected to be one of the fastest growing markets during the forecast years on account of rising product consumption in Japan, China, India and South Korea. In addition, increasing awareness regarding cancer treatment options will drive growth further.


Growth Factors:


  • Increasing demand for anticancer drugs
  • Rising prevalence of cancer
  • Growing investments in research and development of new cancer therapies
  • Technological advancements in hydroxycamptothecin production process
  • Increasing awareness about hydroxycamptothecin as an anticancer drug

Scope Of The Report

Report Attributes

Report Details

Report Title

Hydroxycamptothecin Market Research Report

By Type

99% (HPLC), 98% (HPLC), Other

By Application

Pharmaceutical Intermediats, Lab Reagent, Other

By Companies

Chengdu Tianyuan, Hubei Haosun Pharmaceuticals, Starheb Natural Ingredient, Top Pharma, Hubei Chushengwei, Chengdu Tianyuan

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

123

Number of Tables & Figures

87

Customization Available

Yes, the report can be customized as per your need.


Global Hydroxycamptothecin Market Report Segments:

The global Hydroxycamptothecin market is segmented on the basis of:

Types

99% (HPLC), 98% (HPLC), Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceutical Intermediats, Lab Reagent, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Chengdu Tianyuan
  2. Hubei Haosun Pharmaceuticals
  3. Starheb Natural Ingredient
  4. Top Pharma
  5. Hubei Chushengwei
  6. Chengdu Tianyuan

Global Hydroxycamptothecin Market Overview


Highlights of The Hydroxycamptothecin Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 99% (HPLC)
    2. 98% (HPLC)
    3. Other
  1. By Application:

    1. Pharmaceutical Intermediats
    2. Lab Reagent
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Hydroxycamptothecin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Hydroxycamptothecin Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Hydroxycamptothecin is a chemotherapy agent that is used to treat cancer. It works by killing cancer cells.

Some of the key players operating in the hydroxycamptothecin market are Chengdu Tianyuan, Hubei Haosun Pharmaceuticals, Starheb Natural Ingredient, Top Pharma, Hubei Chushengwei, Chengdu Tianyuan.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hydroxycamptothecin Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Hydroxycamptothecin Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Hydroxycamptothecin Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Hydroxycamptothecin Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Hydroxycamptothecin Market Size & Forecast, 2020-2028       4.5.1 Hydroxycamptothecin Market Size and Y-o-Y Growth       4.5.2 Hydroxycamptothecin Market Absolute $ Opportunity

Chapter 5 Global  Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2  Market Size Forecast by Type
      5.2.1 99% (HPLC)
      5.2.2 98% (HPLC)
      5.2.3 Other
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global  Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2  Market Size Forecast by Applications
      6.2.1 Pharmaceutical Intermediats
      6.2.2 Lab Reagent
      6.2.3 Other
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Hydroxycamptothecin Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Hydroxycamptothecin Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America  Analysis and Forecast
   9.1 Introduction
   9.2 North America  Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America  Market Size Forecast by Type
      9.6.1 99% (HPLC)
      9.6.2 98% (HPLC)
      9.6.3 Other
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America  Market Size Forecast by Applications
      9.10.1 Pharmaceutical Intermediats
      9.10.2 Lab Reagent
      9.10.3 Other
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe  Analysis and Forecast
   10.1 Introduction
   10.2 Europe  Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe  Market Size Forecast by Type
      10.6.1 99% (HPLC)
      10.6.2 98% (HPLC)
      10.6.3 Other
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe  Market Size Forecast by Applications
      10.10.1 Pharmaceutical Intermediats
      10.10.2 Lab Reagent
      10.10.3 Other
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific  Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific  Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific  Market Size Forecast by Type
      11.6.1 99% (HPLC)
      11.6.2 98% (HPLC)
      11.6.3 Other
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific  Market Size Forecast by Applications
      11.10.1 Pharmaceutical Intermediats
      11.10.2 Lab Reagent
      11.10.3 Other
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America  Analysis and Forecast
   12.1 Introduction
   12.2 Latin America  Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America  Market Size Forecast by Type
      12.6.1 99% (HPLC)
      12.6.2 98% (HPLC)
      12.6.3 Other
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America  Market Size Forecast by Applications
      12.10.1 Pharmaceutical Intermediats
      12.10.2 Lab Reagent
      12.10.3 Other
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA)  Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA)  Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA)  Market Size Forecast by Type
      13.6.1 99% (HPLC)
      13.6.2 98% (HPLC)
      13.6.3 Other
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA)  Market Size Forecast by Applications
      13.10.1 Pharmaceutical Intermediats
      13.10.2 Lab Reagent
      13.10.3 Other
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Hydroxycamptothecin Market: Competitive Dashboard
   14.2 Global Hydroxycamptothecin Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Chengdu Tianyuan
      14.3.2 Hubei Haosun Pharmaceuticals
      14.3.3 Starheb Natural Ingredient
      14.3.4 Top Pharma
      14.3.5 Hubei Chushengwei
      14.3.6 Chengdu Tianyuan

Our Trusted Clients

Contact Us